Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bull Exp Biol Med ; 153(6): 862-5, 2012 Oct.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-23113304

RESUMO

The effect of artificial acidification of the intestinal content on neurological manifestations of acute severe cyclophosphamide intoxication was studied in rats. The animals were gavaged with 20 ml/kg sulfuric (0.05 M), hydrochloric, boric, or lactic acids (0.1 M) 3 h before intraperitoneal injections of the cytostatic in doses of 0, 200, 600, or 1000 mg/kg. The decrease in pH (by.0) and ammonia-producing activity of the cecal chyme developed within 3 h after administration of acids. Cyclophosphamide caused hyperammonemia; glutamine/ammonia and urea/ammonia ratios in the blood decreased. These changes augmented after administration of acids (boric acid produced maximum and lactic acid minimum effects). Acid treatment resulted in greatest elevation of ammonia level in the portal venous blood and a lesser elevation in the vena cava posterior blood. Acid treatment promoted manifestation of cyclophosphamide neurotoxic effect and animal death. Hence, acidification of the chyme inhibited the formation of ammonia in it, while ammonia release from the gastrointestinal tract into the blood increased; the treatment augmented hyperammonemia and aggravated the neurological manifestations of cyclophosphamide intoxication.


Assuntos
Ciclofosfamida/toxicidade , Mucosa Gástrica/metabolismo , Hiperamonemia/patologia , Síndromes Neurotóxicas/patologia , Doença Aguda , Administração Oral , Amônia/sangue , Animais , Ácidos Bóricos/administração & dosagem , Suco Gástrico/química , Glutamina/sangue , Ácido Clorídrico/administração & dosagem , Concentração de Íons de Hidrogênio/efeitos dos fármacos , Hiperamonemia/complicações , Hiperamonemia/metabolismo , Hiperamonemia/mortalidade , Ácido Láctico/administração & dosagem , Masculino , Síndromes Neurotóxicas/complicações , Síndromes Neurotóxicas/metabolismo , Síndromes Neurotóxicas/mortalidade , Ratos , Estômago/patologia , Ácidos Sulfúricos/administração & dosagem , Taxa de Sobrevida , Ureia/sangue
2.
Radiat Res ; 152(5): 523-9, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10521929

RESUMO

DNA strand breaks that occur after irradiation activate the repair enzyme adenosine diphosphoribosyl transferase, which consumes NAD as a substrate and causes depletion first of neuronal NAD and then of the ATP pool. This is considered to be the crucial link in the mechanism underlying the cerebral radiation syndrome (CRS). In this study, two ways to correct the CRS metabolically were examined: (a) prevention of depletion of NAD after irradiation by administration of the enzyme inhibitor nicotinamide and (b) shunting the NAD-dependent oxidative phosphorylation pathway of ATP resynthesis by administration of a substrate of NAD-independent oxidation, succinate. Cerebral lesions induced by radiation were modeled by irradiation of rats or rat brain homogenates with 150 Gy of X rays. The manifestations of CRS in rats (excitement, convulsions, etc.) closely resembled those seen after acute hypoxia. In brain homogenates, pyruvate tetrazolium-reductase activity decreased after irradiation and could be corrected by addition of NAD after irradiation. Succinate tetrazolium-reductase activity was not affected by irradiation. Oxygen consumption by brain homogenates after irradiation in vitro and in situ decreased, as did oxygen consumption by rats in vivo after cranio-caudal irradiation. Administration of nicotinamide or succinate prevented both the postirradiation decrease in respiration (in both rats in vivo and brain homogenates in vitro) and the development of cerebral radiation syndrome. These results help to clarify the mechanisms underlying CRS and its metabolic correction.


Assuntos
Encéfalo/efeitos da radiação , Lesões Experimentais por Radiação/tratamento farmacológico , Animais , Encéfalo/metabolismo , Masculino , Niacinamida/uso terapêutico , Oxigênio/metabolismo , Doses de Radiação , Lesões Experimentais por Radiação/metabolismo , Ratos , Ratos Wistar , Ácido Succínico/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...